• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物相互作用中熵效应和疏水效应的问题归因

Problematic Attributions of Entropic and Hydrophobic Effects in Drug Interactions.

作者信息

Schneider Hans-Jörg

机构信息

FR Organische Chemie der Universität des Saarlandes, D 66123 Saarbrücken, Germany.

出版信息

ACS Bio Med Chem Au. 2025 Apr 11;5(3):334-341. doi: 10.1021/acsbiomedchemau.4c00148. eCollection 2025 Jun 18.

DOI:10.1021/acsbiomedchemau.4c00148
PMID:40556775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12183581/
Abstract

The ΔG affinity of drugs with biopolymers and the underling noncovalent interactions play an essential role in drug discovery. Supramolecular complexes can be designed for the identification and quantification of specific interactions, including their dependence on the medium; they also secure the additivity of ΔΔG increments. Such analyses have helped to clarify hydrophobic effects in intermolecular associations, which are barely measurable with small alkyl groups, but large in the presence of curved surfaces in which the replacement of hydrogen bond-deficient water molecules by a ligand leads to sizable enthalpy gain. Difficult to predict entropy contributions TΔS to ΔG vary between 5% and over 90%, particularly in drug associations, as is obvious from literature data. As illustrated with several drug complexes, many so-called hydrophobic effects involve in fact van der Waals or dispersive interactions. Measurements with supramolecular porphyrin complexes allowed us to derive dispersive binding contributions for many groups, which exhibit a correlation with polarizability. In consequence, heteroatoms or π-systems always lead to enhanced van der Waals contributions, while for hydrophobic effects the opposite is expected. Binding contributions from supramolecular complexes can in the future also help artificial intelligence approaches in drug discovery, by expansion of hybrid databases with potential ligands containing groups with desired binding contributions.

摘要

药物与生物聚合物的ΔG亲和力以及潜在的非共价相互作用在药物发现中起着至关重要的作用。超分子复合物可用于识别和量化特定相互作用,包括它们对介质的依赖性;它们还确保了ΔΔG增量的加和性。此类分析有助于阐明分子间缔合中的疏水效应,小烷基几乎无法测量这种效应,但在存在弯曲表面的情况下,配体取代氢键缺失的水分子会导致可观的焓增,疏水效应就会很大。从文献数据可以明显看出,难以预测的熵贡献TΔS对ΔG的影响在5%到90%以上之间变化,尤其是在药物缔合中。正如几个药物复合物所示,许多所谓的疏水效应实际上涉及范德华力或色散相互作用。对超分子卟啉复合物的测量使我们能够得出许多基团的色散结合贡献,这些贡献与极化率相关。因此,杂原子或π体系总是会导致范德华力贡献增强,而对于疏水效应,预期情况则相反。超分子复合物的结合贡献未来还可通过用含有具有所需结合贡献基团的潜在配体扩展混合数据库,帮助药物发现中的人工智能方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a525/12183581/b6ba6e97afb3/bg4c00148_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a525/12183581/4a1a4239661f/bg4c00148_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a525/12183581/f4aba2351f95/bg4c00148_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a525/12183581/b712460de002/bg4c00148_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a525/12183581/5f3712abb747/bg4c00148_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a525/12183581/3e5d75a6cdc3/bg4c00148_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a525/12183581/b6ba6e97afb3/bg4c00148_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a525/12183581/4a1a4239661f/bg4c00148_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a525/12183581/f4aba2351f95/bg4c00148_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a525/12183581/b712460de002/bg4c00148_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a525/12183581/5f3712abb747/bg4c00148_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a525/12183581/3e5d75a6cdc3/bg4c00148_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a525/12183581/b6ba6e97afb3/bg4c00148_0005.jpg

相似文献

1
Problematic Attributions of Entropic and Hydrophobic Effects in Drug Interactions.药物相互作用中熵效应和疏水效应的问题归因
ACS Bio Med Chem Au. 2025 Apr 11;5(3):334-341. doi: 10.1021/acsbiomedchemau.4c00148. eCollection 2025 Jun 18.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
9
"Just Ask What Support We Need": Autistic Adults' Feedback on Social Skills Training.“只需询问我们需要什么支持”:成年自闭症患者对社交技能培训的反馈
Autism Adulthood. 2025 May 28;7(3):283-292. doi: 10.1089/aut.2023.0136. eCollection 2025 Jun.
10
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.

本文引用的文献

1
Multispectroscopic and Theoretical Investigation on the Binding Interaction of a Neurodegenerative Drug, Lobeline with Human Serum Albumin: Perturbation in Protein Conformation and Hydrophobic-Hydrophilic Surface.多谱学和理论研究神经退行性药物洛贝林与人血清白蛋白的结合相互作用:蛋白质构象和疏水性-亲水性表面的扰动。
Mol Pharm. 2024 Aug 5;21(8):4169-4182. doi: 10.1021/acs.molpharmaceut.4c00651. Epub 2024 Jul 22.
2
Guided Docking as a Data Generation Approach Facilitates Structure-Based Machine Learning on Kinases.引导对接作为一种数据生成方法,可促进激酶的基于结构的机器学习。
J Chem Inf Model. 2024 May 27;64(10):4009-4020. doi: 10.1021/acs.jcim.4c00055. Epub 2024 May 15.
3
Distinction and Quantification of Noncovalent Dispersive and Hydrophobic Effects.
非共价分散作用和疏水作用的区分与量化
Molecules. 2024 Apr 2;29(7):1591. doi: 10.3390/molecules29071591.
4
Calculations of Absolute Free Energies, Enthalpies, and Entropies for Drug Binding.药物结合的绝对自由能、焓和熵的计算。
J Chem Theory Comput. 2024 Apr 9;20(7):2812-2819. doi: 10.1021/acs.jctc.4c00057. Epub 2024 Mar 27.
5
Energy, water, and protein folding: A molecular dynamics-based quantitative inventory of molecular interactions and forces that make proteins stable.能量、水和蛋白质折叠:基于分子动力学的定量清单,列出了使蛋白质稳定的分子相互作用和力。
Protein Sci. 2024 Feb;33(2):e4905. doi: 10.1002/pro.4905.
6
Hydrophobicity: The door to drug delivery.疏水性:药物传递的大门。
J Pept Sci. 2024 May;30(5):e3558. doi: 10.1002/psc.3558. Epub 2023 Dec 19.
7
Amphiphilic Poly(2-oxazoline)s with Glycine-Containing Hydrophobic Blocks Tailored for Panobinostat- and Imatinib-Loaded Micelles.用于负载帕比司他和伊马替尼的胶束的、具有含甘氨酸疏水嵌段的两亲性聚(2-恶唑啉)
Biomacromolecules. 2023 Dec 11;24(12):5915-5925. doi: 10.1021/acs.biomac.3c00934. Epub 2023 Nov 21.
8
Dispersion Interactions in Condensed Phases and inside Molecular Containers.凝聚相及分子容器内部的色散相互作用
Acc Chem Res. 2023 Dec 5;56(23):3451-3461. doi: 10.1021/acs.accounts.3c00523. Epub 2023 Nov 13.
9
Artificial Intelligence for Drug Discovery: Are We There Yet?人工智能在药物研发中的应用:我们是否已经实现?
Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:527-550. doi: 10.1146/annurev-pharmtox-040323-040828. Epub 2023 Sep 22.
10
The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies.人工智能在药物研发中的作用:挑战、机遇与策略。
Pharmaceuticals (Basel). 2023 Jun 18;16(6):891. doi: 10.3390/ph16060891.